TY - JOUR
T1 - Evolving Role of Radiation Therapy for Hematologic Malignancies
AU - Lee, Chung K.
PY - 2006/4/1
Y1 - 2006/4/1
N2 - Hematologic malignancies are cancers of the blood, bone marrow, or lymph nodes including leukemias, lymphomas (non-Hodgkin's lymphoma), Hodgkin's disease (also called Hodgkin's lymphoma), and myeloma. New cases of leukemia, lymphoma, and myeloma account for nine percent of cancer cases diagnosed in the United States, and these diseases kill about 59,200 persons each year. Extensive research over the past many years has led to an explosion of new therapies resulting in improvement in outcomes. This article discusses the evolving role of radiation therapy for these diseases.
AB - Hematologic malignancies are cancers of the blood, bone marrow, or lymph nodes including leukemias, lymphomas (non-Hodgkin's lymphoma), Hodgkin's disease (also called Hodgkin's lymphoma), and myeloma. New cases of leukemia, lymphoma, and myeloma account for nine percent of cancer cases diagnosed in the United States, and these diseases kill about 59,200 persons each year. Extensive research over the past many years has led to an explosion of new therapies resulting in improvement in outcomes. This article discusses the evolving role of radiation therapy for these diseases.
UR - http://www.scopus.com/inward/record.url?scp=33646778504&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646778504&partnerID=8YFLogxK
U2 - 10.1016/j.hoc.2006.01.020
DO - 10.1016/j.hoc.2006.01.020
M3 - Review article
C2 - 16730303
AN - SCOPUS:33646778504
SN - 0889-8588
VL - 20
SP - 471
EP - 503
JO - Hematology/Oncology Clinics of North America
JF - Hematology/Oncology Clinics of North America
IS - 2
ER -
